Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Controlled Release - Volume 203, 10 April 2015, Pages 67-76

Cynthia M. Fehres, Hakan Kalay, Sven C.M. Bruijns, Sara A.M. Musaafir, Martino Ambrosini, Louis van Bloois, Sandra J. van Vliet, Gert Storm, Juan J. Garcia-Vallejo, Yvette van Kooyk,